Biotechnology & Medical Research
June 22 (Reuters) - Idera Pharmaceuticals Inc -:Idera announces FDA orphan drug designation for IMO-2125 for the treatment of melanoma.Idera Pharmaceuticals Inc - expects to complete enrollment of phase 2 multicenter trial in h2 2017, overall response rate data available in q1 of 2018.Idera...
June 22 (Reuters) - Ionis Pharmaceuticals Inc :On June 19, co entered into agreements with affiliates of Biomed Realty L.P - SEC filing.Ionis Pharmaceuticals - pursuant to which co will purchase real property located at 2855 Gazelle Court, Carlsbad, California for purchase price of $79.4...
Stonepine Capital Management LLC reports 7.6 pct passive stake in CTI Biopharma Corp as of June 6, 2017
June 22 (Reuters) - Stonepine Capital Management LLC :Stonepine Capital Management LLC reports 7.6 percent passive stake in cti biopharma corp as of june 6, 2017 - SEC filing.
June 22 (Reuters) - DIASORIN SPA ::SIGNS COLLABORATION WITH QIAGEN TO DEVELOP NEW TESTS FOR DIASORIN’S LIAISON FAMILY OF ANALYZERS BASED ON REVIEW AND SELECTION PROCESS INVOLVING QIAGEN’S ASSAY TECHNOLOGIES.
No related earnings announcements are currently scheduled within the next 7 days.